Sasamoto, Naoko
Stewart, Paul A.
Wang, Tianyi
Yoder, Sean J.
Chellappan, Srikumar
Hecht, Jonathan L.
Fridley, Brooke L.
Terry, Kathryn L.
Tworoger, Shelley S.
Funding for this research was provided by:
Ovarian Cancer Academy (W81XWH2110320)
Rivkin Center for Ovarian Cancer (2021 Scientific Scholar Award)
National Institutes of Health (P01 CA87969)
Article History
Received: 11 March 2022
Accepted: 4 May 2022
First Online: 13 May 2022
Declarations
:
: Nurses’ Health Studies: The study protocol was approved by the institutional review boards of the Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required.New England Case Control Study: The study was approved by the Institutional Review Board of Brigham and Women’s Hospital, Boston, Massachusetts and Dartmouth College, Hanover, New Hampshire.
: Not applicable.
: S.S.T. received a grant from BMS that is unrelated to this work. The authors have no potential conflicts of interest to declare.